Clinical Trials for Primary Immunodeficiency

Primary immunodeficiency (PI) is not a single disease -- it is a group of more than 400 disorders that affect how your immune system works. If you have been diagnosed with a PI condition such as common variable immunodeficiency (CVID), X-linked agammaglobulinemia, or another disorder in this family, your immune system does not produce or use antibodies the way it should, leaving you more vulnerable to infections.

Treatment usually involves immunoglobulin replacement therapy -- delivered intravenously (IVIG) or subcutaneously (SCIG) -- to give your body the antibodies it cannot make on its own. Clinical trials are advancing both the delivery and effectiveness of these therapies, as well as exploring deeper interventions for some PI conditions.

According to the Immune Deficiency Foundation, more than 500,000 Americans are living with a primary immunodeficiency. Research into better, more accessible treatments is ongoing.

What Types of Trials Are Available?

Immunoglobulin replacement trials study new formulations, delivery methods, and dosing strategies. If you currently receive IVIG at an infusion center, there may be trials studying whether at-home SCIG administration is a viable and equally effective alternative for your specific condition. Gene therapy trials are among the most significant developments in PI research. For conditions like X-linked severe combined immunodeficiency (SCID), gene therapy trials have shown transformative results. These are typically conducted at specialized academic centers. Targeted immunotherapy trials are studying new agents for people with PI conditions that involve immune dysregulation beyond simple antibody deficiency. Observational and registry studies track long-term health outcomes in people with PI, which may not require any change to your current treatment.

Search ClinicalTrials.gov for currently recruiting studies.

Am I Eligible?

Eligibility depends heavily on your specific PI diagnosis. General factors that trial eligibility often depends on include:

- Your confirmed PI diagnosis and which specific disorder you have

- Current treatment history (some trials require prior IVIG use; others specifically seek treatment-naive participants)

- Age (some trials focus specifically on pediatric or adult populations)

- Frequency and severity of infections or complications

- No recent enrollment in other interventional studies

Your immunologist is the right person to help interpret whether you fit a specific trial's criteria. Talk to your doctor before making any decisions about your treatment.

What If My Insurance Denied My Medication?

IVIG and SCIG therapies -- including brand names like Gamunex-C, Privigen, and Hizentra -- are expensive specialty medications, and prior authorization denials are common. If your immunologist has prescribed immunoglobulin therapy and your insurance has denied it, that is not the end of your options.

You can appeal the denial, request a peer-to-peer review, and at the same time explore whether a clinical trial studying IVIG or SCIG alternatives could provide access to treatment. Some trials provide immunoglobulin therapy at no cost as part of the study protocol.

Ellen can help you understand your denial and organize your next steps.

Ellen can help you figure out your next step. Start with Ellen →

Frequently Asked Questions

Are clinical trials for primary immunodeficiency free?

In most cases, yes. Trial sponsors (pharmaceutical companies, universities, or the NIH) cover the cost of the experimental treatment. You may still have costs for routine care — like doctor visits or standard tests — depending on your insurance. Always ask the trial coordinator what costs you might be responsible for before enrolling.

How do I find primary immunodeficiency trials near me?

The best place to start is ClinicalTrials.gov, the official registry of all trials in the US. Search by condition name and filter by your location. Your specialist can also help identify trials at academic medical centers in your region.

Can I join a trial after being denied Gamunex-C or Hizentra?

Yes, and in many cases a denial can actually make you a stronger candidate — trials often enroll patients who have not responded to or cannot access standard treatments. Talk to your doctor about whether your denial history makes you eligible for open trials studying Gamunex-C or Hizentra or similar medications.